{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:17:24Z","timestamp":1788437844319,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T00:00:00Z","timestamp":1387756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10157-013-0925-2","type":"journal-article","created":{"date-parts":[[2013,12,22]],"date-time":"2013-12-22T00:16:34Z","timestamp":1387671394000},"page":"784-794","source":"Crossref","is-referenced-by-count":24,"title":["Significance of combined cyclosporine\u2212prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial"],"prefix":"10.1007","volume":"18","author":[{"name":"The Refractory Nephrotic Syndrome Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mitarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Yorioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashio","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ogahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"925_CR1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","volume":"9","author":"C Ponticelli","year":"1998","unstructured":"Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol. 1998;9:444\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"925_CR2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.2007020166","volume":"18","author":"V Jha","year":"2007","unstructured":"Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol. 2007;18:1899\u2013904.","journal-title":"J Am Soc Nephrol"},{"key":"925_CR3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1523-1755.2004.00518.x","volume":"65","author":"H Shiiki","year":"2004","unstructured":"Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400\u20137.","journal-title":"Kidney Int"},{"key":"925_CR4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","volume":"56","author":"DC Cattran","year":"1999","unstructured":"Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int. 1999;56:2220\u20136.","journal-title":"Kidney Int"},{"key":"925_CR5","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","volume":"59","author":"DC Cattran","year":"2001","unstructured":"Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001;59:1484\u201390.","journal-title":"Kidney Int"},{"key":"925_CR6","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/ndt\/gfl360","volume":"21","author":"E Alexopoulos","year":"2006","unstructured":"Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant. 2006;21:3127\u201332.","journal-title":"Nephrol Dial Transplant"},{"key":"925_CR7","doi-asserted-by":"crossref","unstructured":"Anonymous. Clinical issues in cyclosporine monitoring: report of the task force on cyclosporine monitoring. Clin Chem.;1987 33:1269\u201388.","DOI":"10.1093\/clinchem\/33.7.1269"},{"key":"925_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2125.1990.tb03677.x","volume":"29","author":"A Lindholm","year":"1990","unstructured":"Lindholm A, Henricsson S, Dahlqvist R. The effect of food and bile acid administration on the relative bioavailability of cyclosporin. Br J Clin Pharmacol. 1990;29:541\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"925_CR9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2165\/00003495-199550050-00009","volume":"50","author":"S Noble","year":"1995","unstructured":"Noble S, Markham A. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Drugs. 1995;50:924\u201341.","journal-title":"Drugs"},{"key":"925_CR10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00007890-200205151-00002","volume":"73","author":"B Nashan","year":"2002","unstructured":"Nashan B, Cole E, Levy G, Thervet E. Clinical validation studies of Neoral C2 monitoring: a review. Transplantation. 2002;73:S3\u201311.","journal-title":"Transplantation"},{"key":"925_CR11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00467-004-1508-y","volume":"19","author":"H Tanaka","year":"2004","unstructured":"Tanaka H, Nakahata T, Ito E. Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome. Pediatr Nephrol. 2004;19:1055\u20138.","journal-title":"Pediatr Nephrol"},{"key":"925_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1440-1797.2007.00773.x","volume":"12","author":"A Takeda","year":"2007","unstructured":"Takeda A, Horike K, Onoda H, Ohtsuka Y, Yoshida A, Uchida K, et al. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile. Nephrology. 2007;12:197\u2013204.","journal-title":"Nephrology"},{"key":"925_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10157-008-0112-z","volume":"13","author":"S Shirai","year":"2009","unstructured":"Shirai S, Yasuda T, Tsuchida H, Kuboshima S, Konno Y, Shima Y, et al. Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome. Clin Exp Nephrol. 2009;13:123\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"925_CR14","first-page":"145","volume-title":"The pathology annual no. 3","author":"T Ehrenreich","year":"1968","unstructured":"Ehrenreich T, Churg J. Pathology of membranous nephropathy. In: Sommers SC, editor. The pathology annual no. 3. New York: Appleton-Century-Crofts; 1968. p. 145\u201386."},{"key":"925_CR15","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"DC Cattran","year":"2012","unstructured":"Cattran DC, Feehally J, Cook HT, Fervenza FC, Floege J, Gipson DS, et al. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:S139\u2013274.","journal-title":"Kidney Int Suppl"},{"key":"925_CR16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","volume":"72","author":"DC Cattran","year":"2007","unstructured":"Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007;72:1429\u201347.","journal-title":"Kidney Int"},{"key":"925_CR17","first-page":"78","volume":"53","author":"S Matsuo","year":"2011","unstructured":"Matsuo S, Imai E, Saito T, Taguchi T, Yokoyama H, Narita I. Guidelines for the treatment of nephrotic syndrome. Nihon Jinzo Gakkai Shi. 2011;53:78\u2013122.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"925_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000187219","volume":"63","author":"G Rostoker","year":"1993","unstructured":"Rostoker G, Belghiti D, BenMaadi A, R\u00e9my P, Lang P, Weil B, et al. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron. 1993;63:335\u201341.","journal-title":"Nephron"},{"key":"925_CR19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ndt\/14.4.1036","volume":"14","author":"L Frische","year":"1999","unstructured":"Frische L, Budde K, F\u00e4rber L, Chariss\u00e9 G, Kunz R, Gaedeke J, et al. Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required? Nephrol Dial Transplant. 1999;14:1036\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"925_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s101570050068","volume":"4","author":"H Iida","year":"2000","unstructured":"Iida H, Naito T, Sakai N, Aoki S. Effect of cyclosporine therapy on idiopathic membranous nephropathy presented with refractory nephrotic syndrome. Clin Exp Nephrol. 2000;4:81\u20135.","journal-title":"Clin Exp Nephrol"},{"key":"925_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0009-9120(96)00001-X","volume":"29","author":"N Rifai","year":"1996","unstructured":"Rifai N, Chao FF, Pham Q, Thiessen J, Soldin SJ. The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. Clin Biochem. 1996;29:149\u201355.","journal-title":"Clin Biochem"},{"key":"925_CR22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1211\/jpp.58.9.0005","volume":"58","author":"N Sugioka","year":"2006","unstructured":"Sugioka N, Kokuhu T, Okamoto M, Yoshimura N, Ito Y, Shibata N, et al. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients. J Pharm Pharmacol. 2006;58:1193\u2013200.","journal-title":"J Pharm Pharmacol"},{"key":"925_CR23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1567-5769(03)00097-3","volume":"3","author":"M Brunet","year":"2003","unstructured":"Brunet M, Campistol JM, Mill\u00e1n O, Vidal E, Esforzado N, Rojo I, et al. Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C2. Int Immunopharmacol. 2003;3:987\u201399.","journal-title":"Int Immunopharmacol"},{"key":"925_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ndt\/gfg434","volume":"19","author":"G Einecke","year":"2004","unstructured":"Einecke G, Mai I, Fritsche L, Slowinski T, Waiser J, Neumayer HH, et al. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression. Nephrol Dial Transplant. 2004;19:215\u201322.","journal-title":"Nephrol Dial Transplant"},{"issue":"9 Suppl","key":"925_CR25","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00007890-200205151-00003","volume":"73","author":"G Levy","year":"2002","unstructured":"Levy G, Thervet E, Lake J, Uchida K. Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation. 2002;73(9 Suppl):S12\u20138.","journal-title":"Transplantation"},{"key":"925_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0012.2005.00343.x","volume":"19","author":"K Praditpornsilpa","year":"2005","unstructured":"Praditpornsilpa K, Avihingsanon Y, Nivatvong S, Kansanabuch T, Eiam-Ong S, Tiranathanagul K, et al. Outcome of microemulsion cyclosporine C2 concentration monitoring in kidney transplantation. Clin Transplant. 2005;19:335\u20139.","journal-title":"Clin Transplant"},{"key":"925_CR27","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.transproceed.2008.06.030","volume":"40","author":"SM Wang","year":"2008","unstructured":"Wang SM, Lai MK, Chueh SC, Tai HC, Chung SD. Optimal C2 concentration of cyclosporin corrected with good efficacy and safety in Asian kidney transplant recipients. Transplant Proc. 2008;40:2243\u20134.","journal-title":"Transplant Proc"},{"issue":"Suppl","key":"925_CR28","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","volume":"109","author":"GR Crabtree","year":"2002","unstructured":"Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell. 2002;109(Suppl):S67\u201379.","journal-title":"Cell"},{"key":"925_CR29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14:931\u20138.","journal-title":"Nat Med"},{"key":"925_CR30","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/sj.ki.5000317","volume":"69","author":"Y Fujii","year":"2006","unstructured":"Fujii Y, Khoshnoodi J, Takenaka H, Hosoyamada M, Nakajo A, Bessho F, et al. The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases. Kidney Int. 2006;69:1350\u20139.","journal-title":"Kidney Int"},{"key":"925_CR31","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","volume":"70","author":"CY Xing","year":"2006","unstructured":"Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int. 2006;70:1038\u201345.","journal-title":"Kidney Int"},{"key":"925_CR32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.clinbiochem.2004.07.004","volume":"37","author":"Y Kagawa","year":"2004","unstructured":"Kagawa Y, Yanagawa M, Muraki Y, Iwamoto T, Mizutani H, Sugimura Y, et al. Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods. Clin Biochem. 2004;37:1016\u201321.","journal-title":"Clin Biochem"},{"key":"925_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cccn.2004.12.018","volume":"355","author":"D Cattaneo","year":"2005","unstructured":"Cattaneo D, Zenoni S, Murgia S, Merlini S, Baldelli S, Perico N, et al. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation. Clin Chim Acta. 2005;355:153\u201364.","journal-title":"Clin Chim Acta"},{"key":"925_CR34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.transproceed.2008.12.018","volume":"41","author":"E Ventura","year":"2009","unstructured":"Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP. Calcineurin inhibitor determination in whole blood with the RXL Dimension analyzer: a useful tool for immunosuppressive drug monitoring. Transplant Proc. 2009;41:707\u20139.","journal-title":"Transplant Proc"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0925-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0925-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T12:58:51Z","timestamp":1647781131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0925-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,23]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0925-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,23]]}}}